Compare MRNA & GIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRNA | GIL |
|---|---|---|
| Founded | 2010 | 1946 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Building Products |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 11.5B |
| IPO Year | 2018 | 1998 |
| Metric | MRNA | GIL |
|---|---|---|
| Price | $40.11 | $72.18 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 8 |
| Target Price | $31.09 | ★ $75.25 |
| AVG Volume (30 Days) | ★ 13.7M | 1.2M |
| Earning Date | 02-13-2026 | 02-23-2026 |
| Dividend Yield | N/A | ★ 1.25% |
| EPS Growth | N/A | ★ 24.08 |
| EPS | N/A | ★ 3.13 |
| Revenue | $2,232,000,000.00 | ★ $3,362,263,000.00 |
| Revenue This Year | N/A | $7.50 |
| Revenue Next Year | $6.38 | $100.40 |
| P/E Ratio | ★ N/A | $23.15 |
| Revenue Growth | N/A | ★ 4.04 |
| 52 Week Low | $22.28 | $37.16 |
| 52 Week High | $55.20 | $73.05 |
| Indicator | MRNA | GIL |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 68.83 |
| Support Level | $36.66 | $70.88 |
| Resistance Level | $45.50 | $73.05 |
| Average True Range (ATR) | 3.09 | 1.81 |
| MACD | -1.07 | 0.49 |
| Stochastic Oscillator | 19.45 | 85.15 |
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Gildan is a vertically integrated designer and manufacturer of basic apparel, including T-shirts, underwear, socks, and hosiery. Its primary market is the sale of blank T-shirts, sweatshirts, and other apparel to wholesalers, major clothing brands, and printers (printwear). Gildan also sells branded clothing through retail and direct-to-consumer channels. Brands include Gildan, American Apparel, Comfort Colors, and Goldtoe. Gildan produces most of its clothing at factories in Latin America but has been ramping up production at its new facility in Bangladesh. Incorporated in 1984, the Montreal-based company operates internationally but generates nearly 90% of its sales in the US. Gildan is acquiring its US rival Hanesbrands to bolster its consumer and printwear operations.